Clinical trial
Vitamin D, K2 Plus Empagliflozin Combination in Type Two Diabetes Mellitus
NCT05417880 is registered in ClinicalTrials.gov with Scotmann Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vitamin D, K2 Plus Empagliflozin Combination in Type Two Diabetes Mellitus
- Lead sponsor
- Scotmann Pharmaceuticals
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- August 31, 2022
- Completion date
- June 30, 2023
- Enrollment
- 340 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.